Sign up to save your podcasts
Or
Share Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Shaping the Future: Expert Insights on Perioperative Immunotherapy for Gastric/GEJ Cancers
Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers? Credit available for this activity expires: 9/22/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
Are you aware that programmed cell death-ligand 1 (PD-L1) testing may not be needed to guide immunotherapy decisions in resectable gastric/gastroesophageal junction (GEJ) cancers? Credit available for this activity expires: 9/22/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002919?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
JAMA Editors' Summary
138 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
322 Listeners
Diabetes Core Update
101 Listeners
This Week in Cardiology
884 Listeners
Core EM - Emergency Medicine Podcast
264 Listeners
JAMA Clinical Reviews
503 Listeners
AFP: American Family Physician Podcast
701 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
289 Listeners
The Curbsiders Internal Medicine Podcast
3,334 Listeners
Core IM | Internal Medicine Podcast
1,138 Listeners
Annals On Call Podcast
190 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Medicine and the Machine
60 Listeners
Keeping Current CME
25 Listeners
Cardionerds: A Cardiology Podcast
430 Listeners
The Curious Clinicians
373 Listeners